Healthcare technology startups across the GCC attracted US$148 million in disclosed investment between January 2025 and July 2026, according to PitchBook data. The funding signals growing momentum behind technologies that could increasingly influence how clinicians diagnose, monitor and treat patients.
A total of 32 healthtech companies secured funding across five GCC markets. Saudi Arabia led with 17 funded companies, followed by the UAE with 11. Investment has focused on areas including digital health, telehealth, women’s health and AI-driven diagnostics.
AI and Data Move Closer to Clinical Practice
The growing investment is shifting attention from simply digitising healthcare towards using AI and health data to support new clinical applications.
This includes technologies designed to improve prediction, generate biological insights and enable more personalised care. As per the press release, the GCC is also strengthening capabilities in genomics, precision medicine, clinical research and health data, creating opportunities for clinicians to engage with emerging technologies through research, pilots and healthcare partnerships.
One example is Canadian digital health company BioTwin, which is participating in the WHX Tech Xcelerate Startup Competition. Its work with Cleveland Clinic Abu Dhabi includes pilots using virtual human twin technology to create individualised patient profiles for breast cancer screening.
What This Means for Doctors
For clinicians, the key development is the growing opportunity to test and adopt health technologies within real healthcare settings.
The GCC’s regulatory sandboxes, government-backed programmes and institutional partnerships can help startups pilot technologies faster. However, successful adoption will still depend on clinical evidence, regulatory approval, interoperability, workflow integration and measurable benefits for patients and healthcare professionals.
Danielle Brewin Graham, General Partner of Phoenix Fire Ventures and a WHX Tech advisory board member, highlighted the region’s ability to give startups faster access to institutional partners for pilots.
WHX Tech to Connect Clinicians, Startups and Investors
These developments will feature at WHX Tech, taking place from 26–28 January 2027 at Dubai World Trade Centre.
The event’s Investor Programme and Xcelerate Startup Competition will connect healthtech startups with investors, healthcare leaders and potential institutional partners.
For doctors, the event offers an opportunity to see emerging technologies that could move from pilot projects to clinical practice, while assessing their evidence, relevance and potential impact on patient care.